OTC:SMNR | Free Cash Flow | Semnur Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.67M
2025-12-31-$3.61M
2025-03-31-$399,000.00
2024-12-31-$1.41M
2024-03-31-$374,151.00
2023-12-31-$158,996.00
2023-03-31-$240,397.00
2022-12-31-$165,831.00
2022-03-31$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$5.87M
2024-12-31-$4.89M
2023-12-31-$632,783.00
2022-12-31-$426,095.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.